Literature DB >> 2821788

Acute effects of hydralazine and enalapril on contractile function of postischemic "stunned" myocardium.

K Przyklenk1, R A Kloner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821788     DOI: 10.1016/0002-9149(87)91059-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  7 in total

1.  Comparison of the effects of ACE inhibition with those of angiotensin II receptor antagonism on systolic and diastolic myocardial stunning in isolated rabbit heart.

Authors:  C Morales; M Rodríguez; O Scapín; R J Gelpi
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

Review 2.  ACE inhibitors in acute and chronic ischaemia: current status and future promise.

Authors:  E H Sonnenblick; M Zhao; C Eng; T H LeJemtel; S M Factor; J Capasso; P Anversa
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

Review 3.  Congestive heart failure. New frontiers.

Authors:  W W Parmley; K Chatterjee; G S Francis; B G Firth; R A Kloner
Journal:  West J Med       Date:  1991-04

Review 4.  Influence of ACE inhibitors on free radicals and reperfusion injury: pharmacological curiosity or therapeutic hope?

Authors:  J McMurray; M Chopra
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

Review 5.  Cardioprotection by ACE inhibitors in myocardial ischaemia/reperfusion. The importance of bradykinin.

Authors:  G Heusch; J Rose; T Ehring
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 6.  Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease.

Authors:  R Ferrari; C Ceconi; S Curello; P Pepi; A Mazzoletti; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 7.  Relationships between structure and effects of ACE inhibitors: comparative effects in myocardial ischaemic/reperfusion injury.

Authors:  K Przyklenk; R A Kloner
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.